Literature DB >> 28130421

Fatal outcome of tick-borne encephalitis in two patients with rheumatic disease treated with rituximab.

Ann Knight1, Karlis Pauksens2, Gunnel Nordmark1, Eva Kumlien3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28130421     DOI： 10.1093/rheumatology/kew495

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN： 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

Review 1.  Fatal Cache Valley virus meningoencephalitis associated with rituximab maintenance therapy.

Authors:  Yuanquan Yang; Jingxin Qiu; Abigail Snyder-Keller; Yongping Wu; Shufeng Sun; Haixin Sui; Amy B Dean; Laura Kramer; Francisco Hernandez-Ilizaliturri
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

2.  Two Cases of Severe Tick-Borne Encephalitis in Rituximab-Treated Patients in Germany: Implications for Diagnosis and Prevention.

Authors:  Philipp A Steininger; Tobias Bobinger; Wenke Dietrich; De-Hyung Lee; Michael Knott; Christian Bogdan; Klaus Korn; Roland Lang
Journal:  Open Forum Infect Dis       Date:  2017-09-26       Impact factor: 3.835

3.  Fatal Powassan Encephalitis (Deer Tick Virus, Lineage II) in a Patient With Fever and Orchitis Receiving Rituximab.

Authors:  Isaac H Solomon; Kristyn M Spera; Sophia L Ryan; Jeffrey Helgager; Juliana Andrici; Sherif R Zaki; Henrikas Vaitkevicius; Kristoffer E Leon; Michael R Wilson; Joseph L DeRisi; Sophia Koo; Stelios M Smirnakis; Umberto De Girolami
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

4.  Burden of Tick-Borne Encephalitis, Sweden.

Authors:  Daniel Slunge; Anders Boman; Marie Studahl
Journal:  Emerg Infect Dis       Date:  2022-02       Impact factor: 6.883

5. 

Authors:  Hans-Jürgen Laws; Ulrich Baumann; Christian Bogdan; Gerd Burchard; Maximilian Christopeit; Jane Hecht; Ulrich Heininger; Inken Hilgendorf; Winfried Kern; Kerstin Kling; Guido Kobbe; Wiebe Külper; Thomas Lehrnbecher; Roland Meisel; Arne Simon; Andrew Ullmann; Maike de Wit; Fred Zepp
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2020-05       Impact factor: 1.513
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.